Author Interviews, Lancet, OBGYNE, Pediatrics, Weight Research / 28.03.2019
Metformin in Pregnancy Associated With Increased Obesity in Children
MedicalResearch.com Interview with:
Liv Guro Engen Hanem, PhD Candidate
Department of Clinical and Molecular Medicine
Norwegian University of Science and Technology
MedicalResearch.com: What is the background for this study?
Response: The antidiabetic drug metformin is increasingly used in pregnancy: to treat gestational diabetes and type 2 diabetes, and to prevent pregnancy complications related to polycystic ovary syndrome (PCOS) and obesity. Metformin passes the placenta, and the fetus is thus exposed to the drug. Although no teratogenicity has been reported, metformin might have long-term effects on offspring health.
This study is a follow-up of cardiometabolic risk factors of 141 5- to 10-year-old children born in the PregMet study. This study was a double-blind, randomized controlled trial (RCT) designed to test the hypothesis that metformin given throughout pregnancy reduces the prevalence of pregnancy complications that are associated with the common endocrine disorder PCOS. Pregnant women with PCOS were randomized to receive metformin or placebo throughout pregnancy. (more…)